Table 3 Association of Body Mass Index (BMI) at baseline with the odds of outcomes investigated.

From: Association of BMI with radiographic incidence and progression of distal interphalangeal joint osteoarthritis in rheumatoid arthritis patients

Outcome

n (%)

Univariable

Multivariable

OR (95% CI)

P

OR (95% CI)

P

DIP joint OA incidence cohort

1031 (100.0)

Incidence of DIP joint OA

251 (24.3)

1.02 (0.98–1.05)

0.333

1.02 (0.98–1.06)

0.300

Worsening of JSN

80 (7.8)

0.98 (0.92–1.04)

0.476

0.99 (0.93–1.05)

0.744

Worsening in osteophytes

294 (28.5)

1.01 (0.98–1.05)

0.501

1.01 (0.98–1.05)

0.539

Incidence of sclerosis

42 (4.1)

1.01 (0.93–1.09)

0.772

1.00 (0.93–1.08)

0.972

Incidence of erosion

1 (0.1)

0.97 (0.41–1.33)

1.000

0.00 (0.00–Inf)

1.000

DIP joint OA progression cohort

1481 (100.0)

Progression of DIP joint OA

1006 (67.9)

1.01 (0.98–1.04)

0.471

1.01 (0.98–1.04)

0.396

Progression of DIP joint OA (stringent definition*)

591 (39.9)

1.01 (0.99–1.04)

0.314

1.02 (0.99–1.04)

0.241

Worsening of JSN

588 (39.7)

0.99 (0.96–1.02)

0.469

0.99 (0.97–1.02)

0.671

Worsening in osteophytes

969 (65.4)

1.02 (0.99–1.05)

0.154

1.02 (0.99–1.05)

0.243

Incidence of sclerosis

337 (22.8)

1.00 (0.97–1.03)

0.773

0.99 (0.96–1.03)

0.746

Incidence of erosion

95 (6.4)

1.01 (0.95–1.06)

0.749

1.01 (0.96–1.07)

0.634

  1. Results are reported as point estimates of 1 BMI unit (kg/m2) increase at baseline. Univariable analyses were conducted on complete cases only. Multivariable analyses utilized data after multiple imputation and the estimates were adjusted for sex, and baseline values of the following variables: age, ACPA, RF, ESR, disease duration since first symptoms, number of tender joints, number of swollen joints, patient assessed general health VAS score, summed percentage of erosive joint surface destruction in 8 MCP joints, and radiographic observation time. Additionally, adjusted for summed K/L grade in 8 distal interphalangeal (DIP) joints at baseline for the outcomes for the progression cohort. * Progression in at least 2 DIP joints instead of 1. 95% CI, 95% confidence interval; ACPA, anti–citrullinated protein antibody; BMI, body mass index; ESR, erythrocyte sedimentation rate; IQR, interquartile range; MCP, metacarpophalangeal; OR, odds ratio; RF, rheumatoid factor; VAS, visual analog scale .